{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:29:19Z","timestamp":1781198959428,"version":"3.54.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Linkou Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2623-E-182-001-NU"],"award-info":[{"award-number":["111-2623-E-182-001-NU"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-182-043"],"award-info":[{"award-number":["114-2314-B-182-043"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-182-042-MY2"],"award-info":[{"award-number":["113-2314-B-182-042-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["BMRP488"],"award-info":[{"award-number":["BMRP488"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jfma.2025.11.032","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:49:21Z","timestamp":1764794961000},"page":"S89-S98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Updates of nuclear medicine imaging in neurodegenerative disorders"],"prefix":"10.1016","volume":"125","author":[{"given":"Shao-Yi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-4564","authenticated-orcid":false,"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Uei","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-7498","authenticated-orcid":false,"given":"Ing-Tsung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5800","key":"10.1016\/j.jfma.2025.11.032_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"issue":"9996","key":"10.1016\/j.jfma.2025.11.032_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"10004","key":"10.1016\/j.jfma.2025.11.032_bib3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"issue":"10004","key":"10.1016\/j.jfma.2025.11.032_bib4","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","article-title":"Frontotemporal dementia","volume":"386","author":"Bang","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.regg.2019.04.002","article-title":"Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly","volume":"54","author":"Fern\u00e1ndez-Ferreira","year":"2019","journal-title":"Rev Esp Geriatr Gerontol"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib6","first-page":"2937","article-title":"The expanding burden of neurodegenerative diseases: an unmet medical and social need","volume":"16","author":"Wang","year":"2024","journal-title":"Aging Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib7","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimer's Dement"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib8","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1002\/alz.14067","article-title":"Correlates of missed or late versus timely diagnosis of dementia in healthcare settings","volume":"20","author":"Chen","year":"2024","journal-title":"Alzheimer's Dement"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.032_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jfma.2025.11.032_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70648","article-title":"Recent advances in neuroimaging of Alzheimer's disease and related dementias","volume":"21","author":"Ottoy","year":"2025","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimer's Dement"},{"issue":"9","key":"10.1016\/j.jfma.2025.11.032_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2967\/jnumed.121.263239","article-title":"Nuclear medicine and artificial intelligence: best practices for evaluation (the RELAINCE Guidelines)","volume":"63","author":"Jha","year":"2022","journal-title":"J Nucl Med"},{"issue":"5054","key":"10.1016\/j.jfma.2025.11.032_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib15","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","article-title":"Revised criteria for the diagnosis and staging of Alzheimer's disease","volume":"30","author":"Jack","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.032_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.jfma.2025.11.032_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70504","article-title":"Amyloid PET and clinical management in a diverse, cognitively impaired population: the New IDEAS Study","volume":"21","author":"Windon","year":"2025","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.032_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.032_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamaneurol.2023.0997","article-title":"Clinical effect of early vs late amyloid positron emission tomography in memory clinic patients: the AMYPAD-DPMS randomized clinical trial","volume":"80","author":"Altomare","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jfma.2025.11.032_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2025.103765","article-title":"A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research","volume":"46","author":"Iaccarino","year":"2025","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.032_bib23","first-page":"1141","article-title":"Tau protein in neurodegenerative diseases - a review","volume":"58","author":"P\u00eer\u015fcoveanu","year":"2017","journal-title":"Rom J Morphol Embryol"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.24706","article-title":"[F-18]AV-1451 positron emission tomography retention in choroid plexus: more than \"off-target\" binding","volume":"80","author":"Ikonomovic","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"(18)F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","author":"Harada","year":"2016","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","article-title":"Tau PET imaging: present and future directions","volume":"12","author":"Saint-Aubert","year":"2017","journal-title":"Mol Neurodegener"},{"issue":"7","key":"10.1016\/j.jfma.2025.11.032_bib28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2967\/jnumed.121.262985","article-title":"In vivo (18)F-flortaucipir PET does not accurately support the staging of progressive supranuclear palsy","volume":"63","author":"Malpetti","year":"2022","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib29","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00259-022-06104-0","article-title":"(18)F-florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy","volume":"50","author":"Liu","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/geriatrics10010027","article-title":"Tau imaging: use and implementation in new diagnostic and therapeutic paradigms for Alzheimer's disease","volume":"10","author":"Gogola","year":"2025","journal-title":"Geriatrics"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00441-017-2706-9","article-title":"Neurodegeneration and the ordered assembly of \u03b1-synuclein","volume":"373","author":"Spillantini","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"11","key":"10.1016\/j.jfma.2025.11.032_bib33","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/cells14110834","article-title":"\u03b1-synuclein PET imaging: from clinical utility in multiple system atrophy to the possible diagnosis of Parkinson's disease","volume":"14","author":"Capotosti","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib34","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","article-title":"The \u03b1-synuclein PET tracer [(18)F]ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases","volume":"14","author":"Smith","year":"2023","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.jfma.2025.11.032_bib35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/cells14161272","article-title":"Current status of \u03b1-synuclein biomarkers and the need for \u03b1-synuclein PET tracers","volume":"14","author":"Berman","year":"2025","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/mds.28984","article-title":"\u03b1-Synuclein radiotracer development and in vivo imaging: recent advancements and new perspectives","volume":"37","author":"Alzghool","year":"2022","journal-title":"Mov Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.jfma.2025.11.032_bib37","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.2967\/jnumed.121.263194","article-title":"[(18)F]FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with copathologies","volume":"63","author":"Minoshima","year":"2022","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.032_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.semnuclmed.2021.01.002","article-title":"Brain [(18)F]FDG PET for clinical dementia workup: differential diagnosis of Alzheimer's disease and other types of dementing disorders","volume":"51","author":"Minoshima","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.032_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.semnuclmed.2025.04.007","article-title":"18F-FDG PET for dementia evaluation: co-pathologies, new diseases, and its roles in the era of antiamyloid treatment","volume":"55","author":"Thientunyakit","year":"2025","journal-title":"Semin Nucl Med"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/imj.14890","article-title":"Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and [(18)F]fluoro-2-deoxyglucose positron emission tomography in the diagnosis of Alzheimer disease","volume":"51","author":"Nadebaum","year":"2021","journal-title":"Intern Med J"},{"issue":"11","key":"10.1016\/j.jfma.2025.11.032_bib41","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s11604-024-01612-5","article-title":"Brain perfusion SPECT in dementia: what radiologists should know","volume":"42","author":"Imokawa","year":"2024","journal-title":"Jpn J Radiol"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.032_bib42","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41380-023-02215-8","article-title":"The use of neuroimaging techniques in the early and differential diagnosis of dementia","volume":"28","author":"Chouliaras","year":"2023","journal-title":"Mol Psychiatr"},{"issue":"20","key":"10.1016\/j.jfma.2025.11.032_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011234","article-title":"Dopamine transporter imaging, current status of a potential biomarker: a comprehensive review","volume":"22","author":"Palermo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","article-title":"[(123)I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease","volume":"62","author":"Booij","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.032_bib45","first-page":"584","article-title":"Binding of [(99m)Tc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers","volume":"41","author":"Mozley","year":"2000","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.032_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043773","article-title":"The titrated mannitol improved central [(99m)Tc]TRODAT-1 uptake in an animal model\u2014a clinically feasible application","volume":"24","author":"Chang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib47","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1007\/s00330-025-11388-5","article-title":"The basics of PET molecular imaging in neurodegenerative disorders with dementia and\/or parkinsonism","volume":"35","author":"Bronte","year":"2025","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae345","article-title":"Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [(18)F]FE-PE2I PET: independent validation with new insights","volume":"6","author":"Honhar","year":"2024","journal-title":"Brain Commun"},{"issue":"22","key":"10.1016\/j.jfma.2025.11.032_bib49","doi-asserted-by":"crossref","first-page":"e2314","DOI":"10.1212\/WNL.0000000000207748","article-title":"Using (18)F-AV-133 VMAT2 PET imaging to monitor progressive nigrostriatal degeneration in Parkinson disease","volume":"101","author":"Beauchamp","year":"2023","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jfma.2025.11.032_bib50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/RLU.0000000000006024","article-title":"A head-to-head comparison of (18)F-FP-CIT and (18)F-FDOPA PET\/CT in early Parkinson disease","volume":"50","author":"Yoo","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"11","key":"10.1016\/j.jfma.2025.11.032_bib51","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209453","article-title":"Neuropathologic validation and diagnostic accuracy of presynaptic dopaminergic imaging in the diagnosis of parkinsonism","volume":"102","author":"Hastings","year":"2024","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib52","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2967\/jnumed.119.229443","article-title":"Neuroinflammation PET imaging: current opinion and future directions","volume":"61","author":"Jain","year":"2020","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.032_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040785","article-title":"Translocator protein-18 kDa (TSPO) positron emission tomography (PET) imaging and its clinical impact in neurodegenerative diseases","volume":"18","author":"Dupont","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.jfma.2025.11.032_bib54","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0024-3205(83)90062-0","article-title":"Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies","volume":"32","author":"Le","year":"1983","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroimage.2012.06.055","article-title":"Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates","volume":"63","author":"Hannestad","year":"2012","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2967\/jnumed.107.046151","article-title":"DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization","volume":"49","author":"James","year":"2008","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-016-0778-1","article-title":"Microglial activation in Parkinson's disease using [18F]-FEPPA","volume":"14","author":"Ghadery","year":"2017","journal-title":"J Neuroinflammation"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.apsb.2020.08.006","article-title":"Recent developments on PET radiotracers for TSPO and their applications in neuroimaging","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.032_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/ijms20030563","article-title":"Binding affinity of some endogenous and synthetic TSPO ligands regarding the rs6971 polymorphism","volume":"20","author":"Berroter\u00e1n-Infante","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.032_bib60","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/life11060484","article-title":"Impact of TSPO receptor polymorphism on [(18)F]GE-180 binding in healthy brain and pseudo-reference regions of neurooncological and neurodegenerative disorders","volume":"11","author":"Vettermann","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.jfma.2025.11.032_bib61","article-title":"Development and clinical application of positron emission tomography imaging agents for monoamine oxidase B","volume":"15","author":"Meyer","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jfma.2025.11.032_bib62","doi-asserted-by":"crossref","DOI":"10.1007\/s12149-025-02083-y","article-title":"Kinetic and quantitative analysis of [(18)F]SMBT-1 PET imaging for monoamine oxidase B","author":"Hiraoka","year":"2025","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib63","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3906\/sag-2008-253","article-title":"Dopamine transporter SPECT imaging in Parkinson's disease and parkinsonian disorders","volume":"51","author":"Akdemir","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"11","key":"10.1016\/j.jfma.2025.11.032_bib64","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2967\/jnumed.116.189266","article-title":"Diagnostic performance of the visual reading of (123)I-ioflupane SPECT images with or without quantification in patients with movement disorders or dementia","volume":"58","author":"Booij","year":"2017","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib65","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00259-016-3601-4","article-title":"Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging","volume":"44","author":"Pontecorvo","year":"2017","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib66","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2967\/jnumed.124.268119","article-title":"Quantification supports amyloid PET visual assessment of challenging cases: results from the AMYPAD diagnostic and patient management study","volume":"66","author":"Collij","year":"2025","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.032_bib67","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","article-title":"Quantification of amyloid PET for future clinical use: a state-of-the-art review","volume":"49","author":"Pemberton","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.032_bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nimg.1997.0303","article-title":"Parametric imaging of ligand-receptor binding in PET using a simplified reference region model","volume":"6","author":"Gunn","year":"1997","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.jfma.2025.11.032_bib69","first-page":"1959","article-title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.032_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","article-title":"A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography","volume":"15","author":"Mintun","year":"1984","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib71","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/jcbfm.1986.96","article-title":"Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches","volume":"6","author":"Huang","year":"1986","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.032_bib72","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.117.200006","article-title":"Flortaucipir F 18 quantitation using parametric estimation of reference signal intensity","volume":"59","author":"Southekal","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jfma.2025.11.032_bib73","article-title":"Parametric estimation of reference signal intensity for semi-quantification of tau deposition: a flortaucipir and [(18)F]-APN-1607 study","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jfma.2025.11.032_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejmp.2021.02.017","article-title":"Centiloid scale analysis for (18)F-THK5351 PET imaging in Alzheimer's disease","volume":"82","author":"Yamao","year":"2021","journal-title":"Phys Med"},{"issue":"9","key":"10.1016\/j.jfma.2025.11.032_bib75","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1002\/alz.13908","article-title":"Harmonizing tau positron emission tomography in Alzheimer's disease: the CenTauR scale and the joint propagation model","volume":"20","author":"Leuzy","year":"2024","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.jfma.2025.11.032_bib76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuroimage.2018.08.044","article-title":"Implementing the centiloid transformation for (11)C-PiB and \u03b2-amyloid (18)F-PET tracers using CapAIBL","volume":"183","author":"Bourgeat","year":"2018","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib77","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12149-025-02051-6","article-title":"Comparison and cutoff values of two amyloid PET scaling methods: centiloid scale and amyloid-\u03b2 load","volume":"39","author":"Yamakuni","year":"2025","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jfma.2025.11.032_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102739","article-title":"Fluid-based biomarkers for neurodegenerative diseases","volume":"108","author":"Cao","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.032_bib79","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib80","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14297","article-title":"The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer's disease and tau burden","volume":"21","author":"Huang","year":"2025","journal-title":"Alzheimer's Dement"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.032_bib82","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2967\/jnumed.123.267360","article-title":"Improving [(18)F]FDG PET quantification through a spatial normalization method","volume":"65","author":"Kim","year":"2024","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.032_bib83","first-page":"354","article-title":"Accurate automated quantification of dopamine transporter PET without MRI using deep learning-based spatial normalization","volume":"58","author":"Kang","year":"2024","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.jfma.2025.11.032_bib84","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s40846-025-00972-1","article-title":"The development of an automatic amyloid PET quantification (AmPQ) software with MR-based and MR-free spatial normalization","volume":"45","author":"Huang","year":"2025","journal-title":"J Med Biol Eng"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/jon.70038","article-title":"Semiautomatic quantification of (99m)Tc-TRODAT-1 SPECT images in patients with idiopathic Parkinson's disease","volume":"35","author":"Chan","year":"2025","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.jfma.2025.11.032_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/461625","article-title":"Fully automated quantification of the striatal uptake ratio of [(99m)Tc]TRODAT with SPECT imaging: evaluation of the diagnostic performance in Parkinson's disease and the temporal regression of striatal tracer uptake","volume":"2015","author":"Fang","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jfma.2025.11.032_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1073720","article-title":"Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson's disease","volume":"9","author":"Boccalini","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41824-024-00205-9","article-title":"Absolute quantitation of sympathetic nerve activity using [(123)I] metaiodobenzylguanidine SPECT-CT in neurology","volume":"8","author":"Saito","year":"2024","journal-title":"EJNMMI Rep"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14600","article-title":"Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data","volume":"21","author":"Karlsson","year":"2025","journal-title":"Alzheimer's Dement"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib90","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1007\/s00330-024-11158-9","article-title":"Using interpretable deep learning radiomics model to diagnose and predict progression of early AD disease spectrum: a preliminary [(18)F]FDG PET study","volume":"35","author":"Jiang","year":"2025","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.032_bib91","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/RLU.0000000000005966","article-title":"A robust residual three-dimensional convolutional neural networks model for prediction of amyloid-\u03b2 positivity by using FDG-PET","volume":"50","author":"Ardakani","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.032_bib92","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12149-024-01950-4","article-title":"Sympathetic (123)I-metaiodobenzylguanidine index for Lewy body disease: probability-based diagnosis and identifying patients exempt from late imaging","volume":"38","author":"Nakajima","year":"2024","journal-title":"Ann Nucl Med"},{"issue":"11","key":"10.1016\/j.jfma.2025.11.032_bib93","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias","volume":"19","author":"Ch\u00e9telat","year":"2020","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.032_bib94","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00415-021-10402-2","article-title":"Differentiating dementia with lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities","volume":"269","author":"Orad","year":"2022","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib95","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Park Relat Disord"},{"issue":"11","key":"10.1016\/j.jfma.2025.11.032_bib96","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jalz.2018.06.2855","article-title":"Molecular imaging in dementia: past, present, and future","volume":"14","author":"Laforce","year":"2018","journal-title":"Alzheimer's Dement"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.032_bib97","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib98","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12974-020-01804-6","article-title":"PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study","volume":"17","author":"Shrestha","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.032_bib99","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13550-024-01186-3","article-title":"P2X7 receptor binding in new-onset and secondary progressive MS: a [(11)C]SMW139 PET study","volume":"14","author":"Lehto","year":"2024","journal-title":"EJNMMI Res"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.032_bib100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/YCO.0000000000001025","volume":"38","author":"Radanovic","year":"2025","journal-title":"Curr Opin Psychiatr"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:35:54Z","timestamp":1781159754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625006394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":100,"alternative-id":["S0929664625006394"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.11.032","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates of nuclear medicine imaging in neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}